GO:0035794 positive regulation of mitochondrial membrane permeability: Mitochondrial Permeability Transition, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035794 describes any process that increases the frequency, rate or extent of molecule passage or uptake across the mitochondrial membrane, commonly studied as the mitochondrial permeability transition (MPT).
• The mitochondrial permeability transition pore (mPTP) is a high-conductance channel whose opening is triggered by calcium overload and oxidative stress, leading to mitochondrial swelling and cell death.
• Key regulators include VDAC in the outer membrane, adenine nucleotide translocase (ANT), cyclophilin D (PPIF), and the SPG7 subunit of the m-AAA protease.
• mPTP opening is implicated in acute kidney injury, bone aging, chronic obstructive pulmonary disease (COPD), and transplant-related endothelial immunogenicity.
• Pharmacological modulators such as cyclosporine A and multidrug resistance modulators can inhibit or modulate mPTP opening, offering therapeutic avenues.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of mPTP regulators in disease.
Description
The mitochondrial permeability transition (MPT) is a sudden increase in the permeability of the inner mitochondrial membrane to solutes and water, driven by the opening of a high-conductance channel known as the mitochondrial permeability transition pore (mPTP). This process is a critical event in cell death and is tightly regulated by calcium, reactive oxygen species, and a suite of mitochondrial proteins. GO:0035794, positive regulation of mitochondrial membrane permeability, captures the biological processes that enhance the passage or uptake of molecules across the mitochondrial membrane, a phenomenon central to both physiology and pathology. Researchers study this term to understand how mitochondria decide between life and death, and to identify therapeutic targets for diseases ranging from acute kidney injury to cancer and neurodegeneration.
positive regulation of mitochondrial membrane permeability At A Glance
| GO ID | GO:0035794 |
|---|---|
| GO term | positive regulation of mitochondrial membrane permeability |
| Ontology | biological_process |
| Synonym | mitochondrial membrane permeability transition, mitochondrial membrane permeabilization, mitochondrial permeability transition, MPT, positive regulation of transport across mitochondrial membrane |
| Major function | Increases the passage or uptake of molecules across the mitochondrial membrane, often via mPTP opening |
| Key regulators | VDAC, ANT, cyclophilin D (PPIF), SPG7, Bax, Bcl-2 family proteins |
| Associated diseases | Acute kidney injury, bone aging, COPD, transplant rejection, cancer |
| Research methods | Patch-clamp, calcium retention capacity, CRISPR knockout/knock-in, bioinformatics |
What Is GO:0035794?
According to the Gene Ontology, GO:0035794 (positive regulation of mitochondrial membrane permeability) is defined as any process that increases the frequency, rate or extent of the passage or uptake of molecules by the mitochondrial membrane. In practice, this often refers to the opening of the mitochondrial permeability transition pore (mPTP), which allows solutes up to 1.5 kDa to cross the inner mitochondrial membrane, leading to mitochondrial swelling, loss of membrane potential, and release of pro-apoptotic factors.
Why Is positive regulation of mitochondrial membrane permeability Important in Cell Biology?
Understanding positive regulation of mitochondrial membrane permeability is crucial because it sits at the crossroads of cell survival and death. Excessive mPTP opening is a hallmark of ischemia-reperfusion injury, neurodegeneration, and aging, while its inhibition can protect tissues. Moreover, cancer cells often evade mPTP-dependent apoptosis, making this process a target for chemotherapeutic strategies. The term also helps researchers integrate molecular mechanisms with disease phenotypes, as seen in acute kidney injury where PGAM5 dephosphorylates Bax to trigger mitochondrial DNA release and inflammation.
• mPTP opening is a key mechanism of cell death in ischemia-reperfusion injury and acute kidney injury.
• It regulates bone metabolism and aging, with cyclophilin D as a critical modulator.
• In COPD, SPG7-mediated mPTP regulation and mitochondrial flickering contribute to disease pathogenesis.
• Endothelial cell immunogenicity in transplantation is influenced by mitochondrial permeability.
• Multidrug resistance modulators can alter mPTP opening, linking permeability to chemotherapy response.
• VDAC in the outer membrane regulates metabolite flux and apoptotic signaling.
• Neutrophil subsets can dictate breast cancer lung metastasis via CD8+ T cell death, a process involving mitochondrial permeability.
• Pharmacological targeting of mPTP (e.g., cyclosporine A) is a therapeutic strategy for multiple diseases.
• CRISPR screens can identify novel regulators of mitochondrial permeability.
• Bioinformatics approaches predict mechanistic frameworks for mPTP regulation in disease.
What Happens During positive regulation of mitochondrial membrane permeability?
Initiation by Calcium Overload and Oxidative Stress
In simple terms: Too much calcium or oxidative stress inside mitochondria triggers the opening of a large pore.
The mitochondrial permeability transition pore (mPTP) is activated by calcium accumulation in the mitochondrial matrix, especially when accompanied by oxidative stress or adenine nucleotide depletion. This opening allows solutes and water to enter, causing mitochondrial swelling and loss of membrane potential. The process is dynamic, with dual dynamics of opening and closing that can be measured experimentally.
Conformational Changes of the mPTP Complex
In simple terms: The pore is made of several proteins that change shape to form a channel.
The molecular identity of the mPTP remains debated, but key components include the adenine nucleotide translocase (ANT) in the inner membrane, cyclophilin D (PPIF) in the matrix, and the voltage-dependent anion channel (VDAC) in the outer membrane. Upon calcium binding to cyclophilin D, ANT undergoes conformational changes that facilitate pore opening. SPG7, a subunit of the m-AAA protease, has also been shown to regulate mPTP and mitochondrial flickering.
Mitochondrial Swelling and Outer Membrane Rupture
In simple terms: Water rushes in, the mitochondrion swells, and its outer membrane can burst.
Sustained mPTP opening leads to osmotic swelling of the mitochondrial matrix, which can cause rupture of the outer mitochondrial membrane and release of pro-apoptotic factors such as cytochrome c. This is a point of no return for many cell death pathways. In acute kidney injury, PGAM5-mediated dephosphorylation of Bax promotes mitochondrial DNA release and inflammation, linking permeability to innate immunity.
Regulation by Bcl-2 Family Proteins and Kinases
In simple terms: Pro- and anti-death proteins fine-tune whether the pore opens.
Bcl-2 family proteins, including Bax and Bak, can permeabilize the outer membrane, while Bcl-2 and Bcl-xL inhibit this process. Phosphoglycerate mutase 5 (PGAM5) dephosphorylates Bax to trigger its activation and subsequent mitochondrial DNA release. Additionally, multidrug resistance modulators can influence mPTP opening, suggesting crosstalk with drug efflux pathways.
Consequences for Cell Fate and Inflammation
In simple terms: When the pore opens, cells can die or trigger inflammation.
Depending on the context, mPTP opening can lead to apoptosis, necrosis, or inflammation. In breast cancer lung metastasis, a Ly6Ghigh neutrophil subset dictates CD8+ T cell death via mechanisms involving mitochondrial permeability. In transplantation, endothelial cell immunogenicity is impacted by mitochondrial permeability, influencing graft rejection. Thus, positive regulation of mitochondrial membrane permeability is a central node in cell fate decisions.
Key Genes Involved in GO:0035794 positive regulation of mitochondrial membrane permeability
The following genes and proteins are key players in the positive regulation of mitochondrial membrane permeability, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VDAC1 | Outer membrane channel; regulates metabolite flux and apoptotic signaling | Target for modulating mitochondrial permeability |
| ANT (SLC25A4/5/6) | Inner membrane ADP/ATP carrier; component of mPTP | Central to mPTP opening |
| PPIF (Cyclophilin D) | Peptidyl-prolyl isomerase; mPTP regulator | Target of cyclosporine A; key in bone aging |
| SPG7 | m-AAA protease subunit; regulates mPTP and mitochondrial flickering | Implicated in COPD pathogenesis |
| BAX | Pro-apoptotic Bcl-2 family member; permeabilizes outer membrane | Dephosphorylated by PGAM5 in acute kidney injury |
| PGAM5 | Phosphoglycerate mutase 5; dephosphorylates Bax | Triggers mitochondrial DNA release and inflammation |
| BCL2 | Anti-apoptotic; inhibits mPTP opening | Modulates cell survival |
| BCL2L1 (Bcl-xL) | Anti-apoptotic; inhibits mitochondrial permeabilization | Potential therapeutic target |
| TP53 | Tumor suppressor; can induce mitochondrial permeability | Links stress responses to mPTP |
| CD8A | T cell co-receptor; involved in T cell death | Mediates neutrophil-induced T cell death in metastasis |
| LY6G | Neutrophil marker; subset dictates metastasis | Linked to mitochondrial permeability in T cells |
| SLC25A3 | Phosphate carrier; may modulate mPTP | Potential regulator |
| ATP5F1B | ATP synthase subunit; possible mPTP component | Debated role in mPTP |
| CypD (PPIF) | Same as PPIF; matrix regulator | Target for mPTP inhibition |
| HIF1A | Hypoxia-inducible factor; may influence mitochondrial permeability | Context-dependent |
| NFKB1 | Inflammation regulator; crosstalk with mPTP | Links permeability to inflammation |
| MAPK1 | Kinase; can modulate mPTP via signaling | Potential upstream regulator |
How Is positive regulation of mitochondrial membrane permeability Regulated?
The positive regulation of mitochondrial membrane permeability is controlled by multiple signaling pathways. Calcium signaling is the primary trigger, with mitochondrial calcium overload promoting mPTP opening. Cyclophilin D (PPIF) acts as a sensitizer, and its inhibition by cyclosporine A blocks pore opening. Kinases such as PGAM5 can dephosphorylate Bax to enhance permeability. Multidrug resistance modulators can also influence mPTP, suggesting crosstalk with drug efflux pathways. In COPD, SPG7-mediated regulation of mPTP and mitochondrial flickering has been proposed as a mechanistic framework. Additionally, Bcl-2 family proteins provide a balance of pro- and anti-permeability signals.
positive regulation of mitochondrial membrane permeability and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PGAM5 | Acute kidney injury | Knockout mouse or cell line |
| PPIF | Bone aging | Cyclophilin D knockout mice |
| SPG7 | COPD | SPG7 knockout or knockdown in lung cells |
| VDAC1 | Transplant rejection | Endothelial cell-specific knockout |
| BAX | Cancer metastasis | Bax knockout in breast cancer models |
Acute Kidney Injury
In acute kidney injury, PGAM5 dephosphorylates the pro-apoptotic protein Bax, triggering mitochondrial DNA release and inflammation. This process is a direct example of positive regulation of mitochondrial membrane permeability contributing to disease pathogenesis.
Bone Metabolism and Aging
The mitochondrial permeability transition plays a role in bone metabolism and aging. Cyclophilin D, a key mPTP regulator, has been implicated in age-related bone loss, making it a potential therapeutic target.
Chronic Obstructive Pulmonary Disease (COPD)
SPG7-mediated regulation of mPTP and mitochondrial flickering has been predicted via bioinformatics to contribute to COPD pathogenesis, highlighting the importance of mitochondrial permeability in respiratory disease.
Transplantation and Endothelial Immunogenicity
Mitochondrial permeability impacts endothelial cell immunogenicity in transplantation, influencing graft rejection. Modulating mPTP may improve transplant outcomes.
From positive regulation of mitochondrial membrane permeability-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate mPTP opening? | CRISPR knockout of gene X in HeLa or HEK293 cells, followed by calcium retention capacity assay |
| Does a point mutation in gene Y alter mPTP sensitivity? | CRISPR point mutation knock-in of the mutation, then measure mitochondrial swelling |
| Can overexpression of gene Z protect against mPTP-induced cell death? | CRISPR overexpression (e.g., CRISPRa) or lentiviral overexpression, then apoptosis assay |
| What is the role of gene W in acute kidney injury? | Kidney-specific knockout mouse model, then ischemia-reperfusion injury |
| Does SPG7 regulate mPTP in COPD? | SPG7 knockout in airway epithelial cells, then mitochondrial flickering assay |
| How does mitochondrial permeability affect T cell death? | Co-culture of neutrophils and CD8+ T cells with mPTP inhibitors |
How to Study the positive regulation of mitochondrial membrane permeability Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Calcium retention capacity | Calcium uptake before mPTP opening | Isolated mitochondria from cells or tissues |
| Mitochondrial swelling | Changes in mitochondrial volume | Plate reader-based assay |
| Patch-clamp | Ion channel activity of mPTP | Mitoplast electrophysiology |
| CRISPR knockout screen | Gene essentiality for mPTP regulation | Genome-wide libraries |
| RNA-seq | Transcriptional changes upon mPTP induction | Pathway analysis |
| Proteomics | Protein interactions with mPTP components | Immunoprecipitation-mass spectrometry |
| Live-cell imaging | Mitochondrial membrane potential and ROS | Fluorescent dyes like TMRM |
| Bioinformatics | Prediction of regulatory networks | Integration of omics data |
Calcium Retention Capacity Assay
This assay measures the ability of isolated mitochondria to retain calcium before mPTP opening. It is a standard method to assess positive regulation of mitochondrial membrane permeability.
Mitochondrial Swelling Assay
Monitoring light scattering at 540 nm in isolated mitochondria detects swelling due to mPTP opening, providing a quantitative readout of permeability.
Patch-Clamp Electrophysiology
Patch-clamp of mitoplasts can directly measure mPTP channel activity and its regulation by proteins such as VDAC and ANT.
CRISPR Screening and Bioinformatics
Genome-wide CRISPR knockout screens combined with bioinformatics can identify novel regulators of mitochondrial permeability. For example, SPG7 was predicted via bioinformatics to regulate mPTP in COPD.
How CRISPR Can Be Used to Study GO:0035794 positive regulation of mitochondrial membrane permeability
Knockout
CRISPR knockout of genes such as PGAM5, PPIF, or SPG7 can abolish their function and reveal their role in positive regulation of mitochondrial membrane permeability. For example, PGAM5 knockout reduces Bax dephosphorylation and mitochondrial DNA release in acute kidney injury models.
Point Mutation
Introducing point mutations in genes like ANT or VDAC can mimic disease-associated variants and test their impact on mPTP opening. This approach helps dissect the precise molecular determinants of permeability regulation.
Knock-in
Knock-in of tagged versions of mPTP components (e.g., GFP-tagged cyclophilin D) allows live-cell imaging and proteomic analysis of the pore complex. This can reveal dynamic interactions during permeability transition.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of anti-apoptotic Bcl-2 family proteins can suppress mPTP opening, while overexpression of pro-apoptotic Bax enhances it. Such models are useful for testing therapeutic strategies.
How EDITGENE Supports positive regulation of mitochondrial membrane permeability Research
Researchers studying positive regulation of mitochondrial membrane permeability-related genes often need to determine whether a candidate gene is causally involved in mPTP regulation or simply correlated with the phenotype. EDITGENE provides a comprehensive suite of CRISPR services to establish causality, from knockout to precise point mutations and overexpression, enabling rigorous mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of mitochondrial membrane permeability research.
Frequently Asked Questions About positive regulation of mitochondrial membrane permeability
What is GO:0035794?
GO:0035794 is the Gene Ontology term for positive regulation of mitochondrial membrane permeability, defined as any process that increases the passage or uptake of molecules across the mitochondrial membrane.
What genes are involved in positive regulation of mitochondrial membrane permeability?
Key genes include VDAC1, ANT (SLC25A4/5/6), PPIF (cyclophilin D), SPG7, BAX, PGAM5, and Bcl-2 family members.
What is the mitochondrial permeability transition pore (mPTP)?
The mPTP is a high-conductance channel in the inner mitochondrial membrane that opens in response to calcium overload and oxidative stress, leading to mitochondrial swelling and cell death.
How is mitochondrial membrane permeability measured?
Common methods include calcium retention capacity assays, mitochondrial swelling assays, and patch-clamp electrophysiology of mitoplasts.
What diseases are associated with mPTP opening?
mPTP opening is implicated in acute kidney injury, bone aging, COPD, transplant rejection, and cancer metastasis.
Can CRISPR be used to study mitochondrial permeability?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in mPTP regulation.
What is the role of cyclophilin D in mPTP?
Cyclophilin D (PPIF) is a matrix peptidyl-prolyl isomerase that sensitizes the mPTP to calcium and is a target of cyclosporine A.
How does SPG7 regulate mPTP?
SPG7, a subunit of the m-AAA protease, regulates mPTP and mitochondrial flickering, and has been linked to COPD pathogenesis.
What is the link between mPTP and inflammation?
mPTP opening can release mitochondrial DNA, triggering inflammation, as seen in acute kidney injury via PGAM5-mediated Bax dephosphorylation.
What are the therapeutic strategies targeting mPTP?
Inhibitors such as cyclosporine A and multidrug resistance modulators can block mPTP opening, offering protection in ischemia-reperfusion injury and other conditions.
Conclusion
GO:0035794, positive regulation of mitochondrial membrane permeability, is a fundamental biological process that governs cell fate and disease. Its core mechanism, the opening of the mitochondrial permeability transition pore, is regulated by a complex interplay of calcium, cyclophilin D, Bcl-2 family proteins, and other modulators. Dysregulation of this process contributes to acute kidney injury, bone aging, COPD, and transplant rejection, making it a prime therapeutic target. Advances in CRISPR-based models and bioinformatics are accelerating the discovery of new regulators and drug candidates, promising to translate our understanding of mitochondrial permeability into clinical benefit.
References
- 1. Li J et al.. 2023. Phosphoglycerate mutase 5 initiates inflammation in acute kidney injury by triggering mitochondrial DNA release by dephosphorylating the pro-apoptotic protein Bax.. Kidney Int 103(1):115-133 PMID: 36089186
- 2. Wang R et al.. 2026. The Ly6g(high) Neutrophil Subset Dictates Breast Cancer Lung Metastasis via CD8(+) T Cell Death.. Cancer Commun (Lond) 46:0003 PMID: 41625479
- 3. Wacquier B et al.. 2020. Dual dynamics of mitochondrial permeability transition pore opening.. Sci Rep 10(1):3924 PMID: 32127570
- 4. Sautchuk R Jr et al.. 2023. Role of the Mitochondrial Permeability Transition in Bone Metabolism and Aging.. J Bone Miner Res 38(4):522-540 PMID: 36779737
- 5. Colombini M. 1987. Regulation of the mitochondrial outer membrane channel, VDAC.. J Bioenerg Biomembr 19(4):309-20 PMID: 3305491
- 6. Fedotcheva T et al.. 2022. Involvement of Multidrug Resistance Modulators in the Regulation of the Mitochondrial Permeability Transition Pore.. Membranes (Basel) 12(9) PMID: 36135908
- 7. Xu A et al.. 2026. SPG7-Mediated Regulation of mPTP and Mitochondrial Flickering in COPD: A Bioinformatics-Based Prediction of Mechanistic Framework.. Int J Chron Obstruct Pulmon Dis 21:597903 PMID: 42404999
- 8. Tran DT et al.. 2018. Impact of Mitochondrial Permeability on Endothelial Cell Immunogenicity in Transplantation.. Transplantation 102(6):935-944 PMID: 29538260
